• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6例先天性肾性尿崩症男孩的长期病程

[Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].

作者信息

Kaulitz R, Brodehl J

机构信息

Medizinische Hochschule Hannover, Kinderklinik.

出版信息

Klin Padiatr. 1989 Nov-Dec;201(6):425-30. doi: 10.1055/s-2008-1026741.

DOI:10.1055/s-2008-1026741
PMID:2601280
Abstract

From 1975-1986 6 boys with congenital nephrogenic diabetes insipidus were diagnosed at the age of 3 months to 10 years. Symptoms appeared within the first few weeks of life. The diagnosis was confirmed by polyuria, low urinary osmolality (97-225 mosm/kg H20), hypernatraemia (max. 171 mmol/l) and the missing response to vasopressin. The treatment was variable; 4 boys received only hydrochlorothiazide (2-2.5 mg/kg/d) which lead to a reduction of the daily urinary volume of 26-44%. Hyperelectrolytaemia disappeared and a normal thriving could be achieved. Later an additional treatment with indomethacin (2 mg/kg/d) was necessary in 3 boys because of an increase of polyuria; there was a further reduction of the daily urinary volume of 50-60%. The combination of hydrochlorothiazide and indomethacin in the treatment of the congenital nephrogenic diabetes insipidus was well tolerated and seems to be--especially during the first few years of life--a necessary and effective treatment which allows a normal thriving and psychointellectual development.

摘要

1975年至1986年期间,6名先天性肾性尿崩症男孩在3个月至10岁时被确诊。症状在出生后的头几周内出现。通过多尿、低尿渗透压(97 - 225 mosm/kg H₂O)、高钠血症(最高171 mmol/l)以及对血管加压素无反应得以确诊。治疗方法各异;4名男孩仅接受氢氯噻嗪治疗(2 - 2.5 mg/kg/d),这使每日尿量减少了26% - 44%。高电解质血症消失,患儿得以正常成长。后来,3名男孩因多尿增加,需要加用吲哚美辛(2 mg/kg/d)治疗;每日尿量进一步减少了50% - 60%。氢氯噻嗪和吲哚美辛联合治疗先天性肾性尿崩症耐受性良好,而且似乎是——尤其是在生命的最初几年——一种必要且有效的治疗方法,可使患儿正常成长及心理智力发育。

相似文献

1
[Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].6例先天性肾性尿崩症男孩的长期病程
Klin Padiatr. 1989 Nov-Dec;201(6):425-30. doi: 10.1055/s-2008-1026741.
2
[Clinical characteristics of 7 patients with gestational diabetes insipidus].7例妊娠性尿崩症患者的临床特征
Zhonghua Fu Chan Ke Za Zhi. 2008 Apr;43(4):266-8.
3
Nephrogenic (vasopressin-resistant) diabetes insipidus with the usual X-linked inheritance.具有常见X连锁遗传的肾性(抗血管加压素性)尿崩症。
Birth Defects Orig Artic Ser. 1971 May;7(6):280-1.
4
Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
Pediatr Nephrol. 1987 Jul;1(3):485-90. doi: 10.1007/BF00849258.
5
[Congenital nephrogenic diabetes insipidus: a difficult diagnosis?].[先天性肾性尿崩症:诊断困难?]
Ned Tijdschr Geneeskd. 1997 Mar 29;141(13):609-12.
6
Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
Clin Sci (Lond). 1984 Jun;66(6):709-15. doi: 10.1042/cs0660709.
7
Transient vasopressin-resistant diabetes insipidus of pregnancy.
Obstet Gynecol. 1986 Nov;68(5):726-8.
8
The mechanism of urinary concentration in nephrogenic diabetes insipidus.肾性尿崩症中尿液浓缩的机制。
Pediatr Res. 1977 Jan;11(1 Pt 1):33-6.
9
Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy.血管加压素抵抗性肾性尿崩症。两性霉素B治疗的结果。
Arch Intern Med. 1979 Jan;139(1):86-8.
10
Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.氢氯噻嗪-阿米洛利治疗先天性肾性尿崩症
Am J Nephrol. 1985;5(1):9-13. doi: 10.1159/000166896.

引用本文的文献

1
Long-term growth of children with nephrogenic diabetes insipidus.肾源性尿崩症患儿的长期生长情况。
Pediatr Nephrol. 2008 Nov;23(11):2007-12. doi: 10.1007/s00467-008-0844-8. Epub 2008 Jun 27.
2
Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.非甾体抗炎药在儿童中的风险与益处:与对乙酰氨基酚的比较。
Paediatr Drugs. 2001;3(11):817-58. doi: 10.2165/00128072-200103110-00004.